CLINICAL TRIALS PROFILE FOR FLIBANSERIN
✉ Email this page to a colleague
All Clinical Trials for flibanserin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00277914 ↗ | Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women | Completed | Sprout Pharmaceuticals, Inc | Phase 3 | 2006-01-01 | To estimate the duration of efficacy with continued treatment of double-blind flibanserin or placebo over twenty-four weeks of treatment. |
NCT00360243 ↗ | 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA | Completed | Sprout Pharmaceuticals, Inc | Phase 3 | 2006-07-01 | This trial is designed to assess the safety and efficacy of flibanserin in the treatment of premenopausal women with Hypoactive Sexual Desire Disorder (HSDD) that meet standard diagnostic criteria. Efficacy for flibanserin will be assessed vs. a parallel placebo group. |
NCT00360529 ↗ | 24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder | Completed | Sprout Pharmaceuticals, Inc | Phase 3 | 2006-07-01 | This trial is designed to assess the safety and efficacy of flibanserin in the treatment of premenopausal women with Hypoactive Sexual Desire Disorder (HSDD) that meets standard diagnostic criteria. Efficacy for flibanserin will be assessed vs. a parallel placebo group. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for flibanserin
Condition Name
Clinical Trial Locations for flibanserin
Trials by Country
Clinical Trial Progress for flibanserin
Clinical Trial Phase
Clinical Trial Sponsors for flibanserin
Sponsor Name